Exclusive special offer and discount title banner vector image

GLOBAL BOTULINUM TOXIN MARKET FORECAST 2023-2032

SCOPE OF THE REPORT

Global Botulinum Toxin Market by Type (Type A Botulinum Toxin, Type B Botulinum Toxin) Market by User Demographic (Women, Men) Market by Application (Medical (Chronic Migraine, Muscle Spasm, Overactive Bladder, Hyperhidrosis, Other Medical Applications), Aesthetic (Crow’s Feet, Forehead Lines, Frown Lines/glabellar, Square Jaw/masseter, Other Aesthetic Applications)) Market by End-user (Specialty and Dermatology Clinics, Hospitals and Clinics, Other End-users) by Geography

REQUEST CUSTOMIZATION

MARKET OVERVIEW

The global botulinum toxin market was valued at $6141.80 million in 2022 and is expected to reach $16005.62 million by 2032, growing at a 10.07% CAGR during the forecast period, 2023-2032.

Botulinum toxin is a neurotoxic protein produced by Clostridium botulinum and related species. The toxin is employed for medicinal and aesthetic purposes. In its cosmetic form, it is also referred to as Botox by patients, an injectable that temporarily minimizes or gets rid of wrinkles and fine lines on the face. The most commonly treated areas are frown lines, forehead wrinkles, and crow’s feet around the eyes. Other treated areas include gummy grins, lip lines, heavy jaw muscles, and thick neck bands.

Read our latest blog on the  Botulinum Toxin Market

GROWTH ENABLERS

Key growth enablers of the global botulinum toxin market are: 

  • Surge in demand for aesthetic procedures 
  • Rising geriatric population
    • By 2050, the World Health Organization (WHO) projects that more than 2 billion individuals worldwide are estimated to be beyond the age of 60.
    • According to the study’s findings, the aging population is closely correlated with the rise of the Botox industry since aging skin loses fluid and collagen, leading to wrinkles on the face and neck. 
    • Due to the high number of facial procedures, surgeries, and treatments performed, the market is anticipated to expand overall as the population ages. 
  • Growing demand for non-invasive cosmetic procedures

GROWTH RESTRAINTS

Key growth restraining factors are:

  • Concerns regarding the adverse effects of botulinum toxin
    • Due to its usage for aesthetic objectives to rejuvenate the face and certain regions of the body, botulinum toxin demand has been rising for many years. 
    • However, as the use of botulinum toxin increases, so too have the risks associated with these procedures, which have grown over time.
    • According to a study published in the Clinical, Cosmetic, and Investigational Dermatology Journal in 2019, hemorrhage, erythema, edema, and soreness at the injection sites are some of the negative effects of Botox. Also, possible after receiving Botox injections are headaches.  
    • Other side effects associated with Botox have been observed to include ptosis, nausea, and general malaise. Ptosis is typically brought on by local Botox diffusion that can last for several weeks in individuals receiving treatment for the glabellar region.
    • Therefore, due to the fear of all these side effects, a few patients still do not undergo these procedures and treatments, restraining the growth of the global botulinum toxin market.
  • Lack of reimbursement policies supporting cosmetic procedures

To Know More About This Report, Request a Free Sample Copy

KEY MARKET TRENDS

Global Botulinum Toxin Market | Top Trends

  • Botulinum toxin therapeutic uses have allowed the healthcare industry to expand. More than 80 clinical trials with botulinum toxin are now underway or scheduled, according to the National Clinical Trials (NCT) Registry, for various diseases and at various stages of development. This is likely to have a favorable effect on the market. The increased demand has also led to an increase in product launches worldwide, which has led to an expansion of the use of botulinum toxin for medicinal purposes.
  • People from developed countries increasingly travel to less developed nations for various health services. This is mostly because such nations offer affordable, high-quality medical care. People travel to countries where they can get high-quality medical care at a reasonable price because some aesthetic surgical procedures, like dermal facial fillers, are not covered by insurance in most of North America and Europe. As a result, medical tourism is one of the biggest trends in the global botulinum toxin market.

MARKET SEGMENTATION

Market Segmentation – Type, User Demographic, Application, and End-User –

Market by Type: 

  • Type A Botulinum Toxin
  • The bacterium Clostridium botulinum produced the neurotoxin Type A. The most potent botulinum toxin is type A, followed by type B and type F.
  • Botulinum toxin type A injections are one of the most popular cosmetic procedures for reducing facial lines and wrinkles, typically brought on by repetitive facial muscle contractions. 
  • The injections of Xeomin, Botox, Dysport, and Jeuveau are a few of the more well-known types. Additionally, it is a component of medications used to treat various illnesses, including migraines and muscle spasms. 
  • For instance, Merz Pharmaceuticals’ Boucouture (brand name: Xeomin) is used to treat cervical dystonia and blepharospasm.
  • Type B Botulinum Toxin

Market by User Demographic:

  • Women
  • According to user demographics, the women’s market leads worldwide and is anticipated to grow profitably during the projected period. 
  • Rising female trends for skin rejuvenation in middle age and rising rates of aesthetic surgery are the main contributors to this. 
  • For instance, more than 4.1 million females underwent botulinum toxin surgery in 2020, according to data from the Aesthetic Society. 
  • In addition, the women’s sector exhibits signs of aging, including crow’s feet, frown lines, and forehead wrinkles. Thus, products containing botulinum toxin can reduce these age-related symptoms.
  • Men

Market by Application:

  •  Medical
    • Chronic Migraine
    • Muscle Spasm
    • Overactive Bladder
    • Hyperhidrosis
    • Other Medical Applications
  • Aesthetic
    • Crow’s Feet
    • Forehead Lines
    • Frown Lines/Glabellar
    • Square Jaw/Masseter
    • Other Aesthetic Applications

Market by End-User:

  • Specialty and Dermatology Clinics
  • Hospitals and Clinics
  • Other End-Users

GEOGRAPHICAL STUDY

Geographical Study Based on Four Major Regions:
  • North America: The United States and Canada
  • Europe: The United Kingdom, Germany, France, Italy, Spain, Nordic Countries, Poland, and Rest of Europe
  • Asia-Pacific: China, Japan, India, South Korea, Singapore, Thailand, Australia & New Zealand, and Rest of Asia-Pacific
    • In Asia-Pacific, botulinum toxin type A remains the most often used nonsurgical aesthetic procedure as more and more women seek to alter their inherited traits. Therefore, a growing desire to alter facial morphology and conform to regional beauty standards drives the global botulinum toxin market.
    • However, the availability of fake and counterfeit goods is a problem because doctors and patients can easily buy them from online retailers. 
    • Economic prospects, rising incomes, and shifting purchasing patterns are all expected to boost medical beauty spending in China. Additionally, the number of cases of some strabismuses, adult blepharospasm, prosopospasm, and migraines is increasing in the country, which has increased the demand for botulinum toxin. 
    • Galderma also declared in April 2020 that China’s National Medical Products Administration (NMPA) had permitted Restylane Vital, Restylane Lyft Lidocaine, and Restylane Lidocaine. The business anticipates that this strategy will aid in the portfolio expansion of Restylane in China. The industry under study is anticipated to expand nationwide as more market participants enter.
  • Rest of World: Latin America, the Middle East & Africa

MAJOR PLAYERS

The major players in the global botulinum toxin market are

  • AbbVie  
  • Galderma
  • Merz Pharma
  • Revance Therapeutics Inc

Key strategies adopted by some of these companies:

  • In March 2023, Ipsen stated that it had successfully acquired Albireo Pharma Inc, a pioneer in developing bile-acid modulators to treat uncommon liver disorders. The purchase expands Ipsen’s portfolio of rare diseases with unique pipeline potential, promising therapies for pediatric and adult uncommon cholestatic liver illnesses, and scientific and commercial capabilities.
  • In February 2023, an expanded strategic partnership between AbbVie and Capsida Biotherapeutics Inc. was announced to create genetic treatments for serious eye conditions.
  • In April 2023, Galderma declared that Sculptra®, an injectable poly-L-lactic acid (PLLA-SCA), had received FDA approval to treat wrinkles and fine lines around the cheeks. Sculptra is the first and only PLLA collagen stimulator approved by the FDA. When injected into the cheek area, it helps stimulate the body’s collagen production to reduce wrinkles and enhance skin characteristics like firmness and radiance.
  • In January 2023, Galderma inaugurated its new Global Capability Center in Barcelona, Spain, enabling the company to use new capabilities to help its international commercial and functional teams once this center is established.

REPORT SYNOPSIS

REPORT SCOPEDETAILS
Market Forecast Years2023-2032
Base Year2022
Market Historical Years2018-2022
Forecast UnitsRevenue ($ Million)
Segments AnalyzedType, User Demographic, Application, and End-user
Geographies AnalyzedNorth America, Europe, Asia-Pacific, and Rest of World
Companies Analyzed

AbbVie Inc, Candela Medical, Daewoong Pharmaceutical Co Ltd, Evolus Inc, Galderma, Hugel Inc, Ipsen, Lanzhou Institute of Biological Products Co Ltd, Medytox, Merz Pharma, Revance Therapeutics Inc, US WorldMeds LLC

TABLE OF CONTENT

  1. RESEARCH SCOPE & METHODOLOGY
    1. STUDY OBJECTIVES
    2. METHODOLOGY
    3. ASSUMPTIONS & LIMITATIONS
  2. EXECUTIVE SUMMARY
    1. MARKET SIZE & ESTIMATES
    2. MARKET OVERVIEW
    3. SCOPE OF STUDY
    4. CRISIS SCENARIO ANALYSIS
      1. IMPACT OF COVID-19 ON BOTULINUM TOXIN MARKET
    5. MAJOR MARKET FINDINGS
      1. FAVORABLE REGULATORY APPROVALS ADD TO MARKET GROWTH
      2. GROWING AWARENESS ABOUT ‘NOTOX’
      3. INFLATING COSMETIC TOURISM ADDS TO THE DEMAND FOR BOTULINUM TOXIN
  3. MARKET DYNAMICS
    1. KEY DRIVERS
      1. SURGE IN DEMAND FOR AESTHETIC PROCEDURES
      2. RISING GERIATRIC POPULATION
      3. GROWING DEMAND FOR NON-INVASIVE COSMETIC PROCEDURES 
    2. KEY RESTRAINTS
      1. CONCERNS REGARDING THE ADVERSE EFFECTS OF BOTULINUM TOXIN
      2. LACK OF REIMBURSEMENT POLICIES SUPPORTING COSMETIC PROCEDURES
  4. KEY ANALYTICS
    1. KEY MARKET TRENDS
    2. PORTER’S FIVE FORCES ANALYSIS
      1. BUYERS POWER
      2. SUPPLIERS POWER
      3. SUBSTITUTION
      4. NEW ENTRANTS
      5. INDUSTRY RIVALRY
    3. GROWTH PROSPECT MAPPING
      1. GROWTH PROSPECT MAPPING FOR UNITED STATES
      2. GROWTH PROSPECT MAPPING FOR GERMANY
      3. GROWTH PROSPECT MAPPING FOR CHINA
      4. GROWTH PROSPECT MAPPING FOR BRAZIL
    4. MARKET MATURITY ANALYSIS
    5. MARKET CONCENTRATION ANALYSIS
  5. MARKET BY TYPE
    1. TYPE A BOTULINUM TOXIN
    2. TYPE B BOTULINUM TOXIN
  6. MARKET BY USER DEMOGRAPHIC
    1. WOMEN
    2. MEN
  7. MARKET BY APPLICATION
    1. MEDICAL
      1. CHRONIC MIGRAINE
      2. MUSCLE SPASM
      3. OVERACTIVE BLADDER
      4. HYPERHIDROSIS
      5. OTHER MEDICAL APPLICATIONS
    2. AESTHETIC
      1. CROW’S FEET
      2. FOREHEAD LINES
      3. FROWN LINES/GLABELLAR
      4. SQUARE JAW/MASSETER
      5. OTHER AESTHETIC APPLICATIONS
  8. MARKET BY END-USER
    1. SPECIALTY AND DERMATOLOGY CLINICS
    2. HOSPITALS AND CLINICS
    3. OTHER END-USERS
  9. GEOGRAPHICAL ANALYSIS
    1. NORTH AMERICA
      1. MARKET SIZE & ESTIMATES
      2. NORTH AMERICA BOTULINUM TOXIN MARKET DRIVERS
      3. NORTH AMERICA BOTULINUM TOXIN MARKET CHALLENGES
      4. NORTH AMERICA BOTULINUM TOXIN MARKET REGULATORY FRAMEWORK
      5. KEY PLAYERS IN NORTH AMERICA BOTULINUM TOXIN MARKET
      6. COUNTRY ANALYSIS
        1. UNITED STATES
          1. UNITED STATES BOTULINUM TOXIN MARKET SIZE & OPPORTUNITIES
        2. CANADA
          1. CANADA BOTULINUM TOXIN MARKET SIZE & OPPORTUNITIES
    2. EUROPE
      1. MARKET SIZE & ESTIMATES
      2. EUROPE BOTULINUM TOXIN MARKET DRIVERS
      3. EUROPE BOTULINUM TOXIN MARKET CHALLENGES
      4. EUROPE BOTULINUM TOXIN MARKET REGULATORY FRAMEWORK
      5. KEY PLAYERS IN EUROPE BOTULINUM TOXIN MARKET
      6. COUNTRY ANALYSIS
        1. UNITED KINGDOM
          1. UNITED KINGDOM BOTULINUM TOXIN MARKET SIZE & OPPORTUNITIES
        2. GERMANY
          1. GERMANY BOTULINUM TOXIN MARKET SIZE & OPPORTUNITIES
        3. FRANCE
          1. FRANCE BOTULINUM TOXIN MARKET SIZE & OPPORTUNITIES
        4. ITALY
          1. ITALY BOTULINUM TOXIN MARKET SIZE & OPPORTUNITIES
        5. SPAIN
          1. SPAIN BOTULINUM TOXIN MARKET SIZE & OPPORTUNITIES
        6. NORDIC COUNTRIES
          1. NORDIC COUNTRIES BOTULINUM TOXIN MARKET SIZE & OPPORTUNITIES
        7. POLAND
          1. POLAND BOTULINUM TOXIN MARKET SIZE & OPPORTUNITIES
        8. REST OF EUROPE
          1. REST OF EUROPE BOTULINUM TOXIN MARKET SIZE & OPPORTUNITIES
    3. ASIA-PACIFIC
      1. MARKET SIZE & ESTIMATES
      2. ASIA-PACIFIC BOTULINUM TOXIN MARKET DRIVERS
      3. ASIA-PACIFIC BOTULINUM TOXIN MARKET CHALLENGES
      4. ASIA-PACIFIC BOTULINUM TOXIN MARKET REGULATORY FRAMEWORK
      5. KEY PLAYERS IN ASIA-PACIFIC BOTULINUM TOXIN MARKET
      6. COUNTRY ANALYSIS
        1. CHINA
          1. CHINA BOTULINUM TOXIN MARKET SIZE & OPPORTUNITIES
        2. JAPAN
          1. JAPAN BOTULINUM TOXIN MARKET SIZE & OPPORTUNITIES
        3. INDIA
          1. INDIA BOTULINUM TOXIN MARKET SIZE & OPPORTUNITIES
        4. SOUTH KOREA
          1. SOUTH KOREA BOTULINUM TOXIN MARKET SIZE & OPPORTUNITIES
        5. SINGAPORE
          1. SINGAPORE BOTULINUM TOXIN MARKET SIZE & OPPORTUNITIES
        6. THAILAND
          1. THAILAND BOTULINUM TOXIN MARKET SIZE & OPPORTUNITIES
        7. AUSTRALIA & NEW ZEALAND
          1. AUSTRALIA & NEW ZEALAND BOTULINUM TOXIN MARKET SIZE & OPPORTUNITIES
        8. REST OF ASIA-PACIFIC
          1. REST OF ASIA-PACIFIC BOTULINUM TOXIN MARKET SIZE & OPPORTUNITIES
    4. REST OF WORLD
      1. MARKET SIZE & ESTIMATES
      2. REST OF WORLD BOTULINUM TOXIN MARKET DRIVERS
      3. REST OF WORLD BOTULINUM TOXIN MARKET CHALLENGES
      4. REST OF WORLD BOTULINUM TOXIN REGULATORY FRAMEWORK
      5. KEY PLAYERS IN REST OF WORLD BOTULINUM TOXIN MARKET
      6. REGIONAL ANALYSIS
        1. LATIN AMERICA
          1. LATIN AMERICA BOTULINUM TOXIN MARKET SIZE & OPPORTUNITIES
        2. MIDDLE EAST & AFRICA
          1. MIDDLE EAST & AFRICA BOTULINUM TOXIN MARKET SIZE & OPPORTUNITIES
  10. COMPETITIVE LANDSCAPE
    1. KEY STRATEGIC DEVELOPMENTS
      1. ACQUISITIONS
      2. PRODUCT LAUNCHES & DEVELOPMENTS
      3. PARTNERSHIPS
      4. BUSINESS EXPANSIONS
    2. COMPANY PROFILES
      1. ABBVIE
        1. COMPANY OVERVIEW
        2. PRODUCT LIST
        3. STRENGTHS & CHALLENGES
      2. CANDELA MEDICAL
        1. COMPANY OVERVIEW
        2. PRODUCT LIST
        3. STRENGTHS & CHALLENGES
      3. DAEWOONG PHARMACEUTICAL CO LTD
        1. COMPANY PROFILE
        2. PRODUCT LIST
        3. STRENGTHS & CHALLENGES
      4. EVOLUS INC
        1. COMPANY OVERVIEW
        2. PRODUCT LIST
        3. STRENGTHS & CHALLENGES
      5. GALDERMA
        1. COMPANY OVERVIEW
        2. PRODUCT LIST
        3. STRENGTHS & CHALLENGES
      6. HUGEL INC
        1. COMPANY OVERVIEW
        2. PRODUCT LIST
        3. STRENGTHS & CHALLENGES
      7. IPSEN
        1. COMPANY OVERVIEW
        2. PRODUCTS / SERVICES LIST
        3. STRENGTHS & CHALLENGES
      8. LANZHOU INSTITUTE OF BIOLOGICAL PRODUCTS CO LTD
        1. COMPANY OVERVIEW
        2. PRODUCT LIST
        3. STRENGTHS & CHALLENGES
      9. MEDYTOX INC
        1. COMPANY OVERVIEW
        2. PRODUCT LIST
        3. STRENGTHS & CHALLENGES
      10. MERZ PHARMA
        1. COMPANY OVERVIEW
        2. PRODUCT LIST
        3. STRENGTHS & CHALLENGES
      11. REVANCE THERAPEUTICS INC
        1. COMPANY OVERVIEW
        2. PRODUCT LIST
      12. US WORLDMEDS LLC
        1. COMPANY OVERVIEW
        2. PRODUCT LIST

LIST OF TABLES

TABLE 1: MARKET SNAPSHOT – BOTULINUM TOXIN

TABLE 2: EXAMPLE OF COMMERCIALLY AVAILABLE BOTULINUM TOXIN TYPE A FOR AESTHETIC PROCEDURES

TABLE 3: GLOBAL BOTULINUM TOXIN MARKET, BY TYPE, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 4: GLOBAL BOTULINUM TOXIN MARKET, BY TYPE, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 5: GLOBAL TYPE A BOTULINUM TOXIN MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 6: GLOBAL TYPE A BOTULINUM TOXIN MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 7: GLOBAL TYPE B BOTULINUM TOXIN MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 8: GLOBAL TYPE B BOTULINUM TOXIN MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 9: GLOBAL BOTULINUM TOXIN MARKET, BY USER DEMOGRAPHIC, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 10: GLOBAL BOTULINUM TOXIN MARKET, BY USER DEMOGRAPHIC, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 11: GLOBAL WOMEN MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 12: GLOBAL WOMEN MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 13: GLOBAL MEN MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 14: GLOBAL MEN MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 15: GLOBAL BOTULINUM TOXIN MARKET, BY APPLICATION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 16: GLOBAL BOTULINUM TOXIN MARKET, BY APPLICATION, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 17: GLOBAL MEDICAL MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 18: GLOBAL MEDICAL MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 19: GLOBAL BOTULINUM TOXIN MARKET, BY MEDICAL, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 20: GLOBAL BOTULINUM TOXIN MARKET, BY MEDICAL, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 21: GLOBAL CHRONIC MIGRAINE MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 22: GLOBAL CHRONIC MIGRAINE MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 23: GLOBAL MUSCLE SPASM MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 24: GLOBAL MUSCLE SPASM MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 25: GLOBAL OVERACTIVE BLADDER MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 26: GLOBAL OVERACTIVE BLADDER MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 27: GLOBAL HYPERHIDROSIS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 28: GLOBAL HYPERHIDROSIS MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 29: GLOBAL OTHER MEDICAL APPLICATIONS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 30: GLOBAL OTHER MEDICAL APPLICATIONS MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 31: GLOBAL AESTHETIC MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 32: GLOBAL AESTHETIC MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 33: GLOBAL BOTULINUM TOXIN MARKET, BY AESTHETIC, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 34: GLOBAL BOTULINUM TOXIN MARKET, BY AESTHETIC, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 35: GLOBAL CROW’S FEET MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 36: GLOBAL CROW’S FEET MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 37: GLOBAL FOREHEAD LINES MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 38: GLOBAL FOREHEAD LINES MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 39: GLOBAL FROWN LINES/GLABELLAR MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 40: GLOBAL FROWN LINES/GLABELLAR MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 41: GLOBAL SQUARE JAW/MASSETER MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 42: GLOBAL SQUARE JAW/MASSETER MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 43: GLOBAL OTHER AESTHETIC APPLICATIONS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 44: GLOBAL OTHER AESTHETIC APPLICATIONS MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 45: GLOBAL BOTULINUM TOXIN MARKET, BY END-USER, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 46: GLOBAL BOTULINUM TOXIN MARKET, BY END-USER, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 47: GLOBAL SPECIALTY AND DERMATOLOGY CLINICS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 48: GLOBAL SPECIALTY AND DERMATOLOGY CLINICS MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 49: GLOBAL HOSPITALS AND CLINICS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 50: GLOBAL HOSPITALS AND CLINICS MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 51: GLOBAL OTHER END-USERS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 52: GLOBAL OTHER END-USERS MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 53: GLOBAL BOTULINUM TOXIN MARKET, BY GEOGRAPHY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 54: GLOBAL BOTULINUM TOXIN MARKET, BY GEOGRAPHY, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 55: NORTH AMERICA BOTULINUM TOXIN MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 56: NORTH AMERICA BOTULINUM TOXIN MARKET, BY COUNTRY, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 57: NORTH AMERICA BOTULINUM TOXIN MARKET REGULATORY FRAMEWORK

TABLE 58: KEY PLAYERS OPERATING IN NORTH AMERICA BOTULINUM TOXIN MARKET

TABLE 59: EUROPE BOTULINUM TOXIN MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 60: EUROPE BOTULINUM TOXIN MARKET, BY COUNTRY, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 61: EUROPE BOTULINUM TOXIN MARKET REGULATORY FRAMEWORK

TABLE 62: KEY PLAYERS OPERATING IN EUROPE BOTULINUM TOXIN MARKET

TABLE 63: ASIA-PACIFIC BOTULINUM TOXIN MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 64: ASIA-PACIFIC BOTULINUM TOXIN MARKET, BY COUNTRY, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 65: ASIA-PACIFIC BOTULINUM TOXIN MARKET REGULATORY FRAMEWORK

TABLE 66: KEY PLAYERS OPERATING IN ASIA-PACIFIC BOTULINUM TOXIN MARKET

TABLE 67: REST OF WORLD BOTULINUM TOXIN MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 68: REST OF WORLD BOTULINUM TOXIN MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 69: REST OF WORLD BOTULINUM TOXIN MARKET REGULATORY FRAMEWORK

TABLE 70: KEY PLAYERS OPERATING IN REST OF WORLD BOTULINUM TOXIN MARKET

TABLE 71: LIST OF ACQUISITIONS

TABLE 72: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS

TABLE 73: LIST OF PARTNERSHIPS

TABLE 74: LIST OF BUSINESS EXPANSIONS

LIST OF FIGURES 

FIGURE 1: KEY MARKET TRENDS

FIGURE 2: PORTER’S FIVE FORCES ANALYSIS

FIGURE 3: GROWTH PROSPECT MAPPING FOR UNITED STATES

FIGURE 4: GROWTH PROSPECT MAPPING FOR GERMANY

FIGURE 5: GROWTH PROSPECT MAPPING FOR CHINA

FIGURE 6: GROWTH PROSPECT MAPPING FOR BRAZIL

FIGURE 7: MARKET MATURITY ANALYSIS

FIGURE 8: MARKET CONCENTRATION ANALYSIS

FIGURE 9: GLOBAL BOTULINUM TOXIN MARKET, GROWTH POTENTIAL, BY TYPE, IN 2022

FIGURE 10: GLOBAL BOTULINUM TOXIN MARKET, BY TYPE A BOTULINUM TOXIN, 2023-2032 (IN $ MILLION)

FIGURE 11: GLOBAL BOTULINUM TOXIN MARKET, BY TYPE B BOTULINUM TOXIN, 2023-2032 (IN $ MILLION)

FIGURE 12: GLOBAL BOTULINUM TOXIN MARKET, GROWTH POTENTIAL, BY USER DEMOGRAPHIC, IN 2022

FIGURE 13: GLOBAL BOTULINUM TOXIN MARKET, BY WOMEN, 2023-2032 (IN $ MILLION)

FIGURE 14: GLOBAL BOTULINUM TOXIN MARKET, BY MEN, 2023-2032 (IN $ MILLION)

FIGURE 15: GLOBAL BOTULINUM TOXIN MARKET, GROWTH POTENTIAL, BY APPLICATION, IN 2022

FIGURE 16: GLOBAL BOTULINUM TOXIN MARKET, BY MEDICAL, 2023-2032 (IN $ MILLION)

FIGURE 17: GLOBAL BOTULINUM TOXIN MARKET, GROWTH POTENTIAL, BY MEDICAL, IN 2022

FIGURE 18: GLOBAL BOTULINUM TOXIN MARKET, BY CHRONIC MIGRAINE, 2023-2032 (IN $ MILLION)

FIGURE 19: GLOBAL BOTULINUM TOXIN MARKET, BY MUSCLE SPASM, 2023-2032 (IN $ MILLION)

FIGURE 20: GLOBAL BOTULINUM TOXIN MARKET, BY OVERACTIVE BLADDER, 2023-2032 (IN $ MILLION)

FIGURE 21: GLOBAL BOTULINUM TOXIN MARKET, BY HYPERHIDROSIS, 2023-2032 (IN $ MILLION)

FIGURE 22: GLOBAL BOTULINUM TOXIN MARKET, BY OTHER MEDICAL APPLICATIONS, 2023-2032 (IN $ MILLION)

FIGURE 23: GLOBAL BOTULINUM TOXIN MARKET, BY AESTHETIC, 2023-2032 (IN $ MILLION)

FIGURE 24: GLOBAL BOTULINUM TOXIN MARKET, GROWTH POTENTIAL, BY AESTHETIC, IN 2022

FIGURE 25: GLOBAL BOTULINUM TOXIN MARKET, BY CROW’S FEET, 2023-2032 (IN $ MILLION)

FIGURE 26: GLOBAL BOTULINUM TOXIN MARKET, BY FOREHEAD LINES, 2023-2032 (IN $ MILLION)

FIGURE 27: GLOBAL BOTULINUM TOXIN MARKET, BY FROWN LINES/GLABELLAR, 2023-2032 (IN $ MILLION)

FIGURE 28: GLOBAL BOTULINUM TOXIN MARKET, BY SQUARE JAW/MASSETER, 2023-2032 (IN $ MILLION)

FIGURE 29: GLOBAL BOTULINUM TOXIN MARKET, BY OTHER AESTHETIC APPLICATIONS, 2023-2032 (IN $ MILLION)

FIGURE 30: GLOBAL BOTULINUM TOXIN MARKET, GROWTH POTENTIAL, BY END-USER, IN 2022

FIGURE 31: GLOBAL BOTULINUM TOXIN MARKET, BY SPECIALTY AND DERMATOLOGY CLINICS, 2023-2032 (IN $ MILLION)

FIGURE 32: GLOBAL BOTULINUM TOXIN MARKET, BY HOSPITALS AND CLINICS, 2023-2032 (IN $ MILLION)

FIGURE 33: GLOBAL BOTULINUM TOXIN MARKET, BY OTHER END-USERS, 2023-2032 (IN $ MILLION)

FIGURE 34: NORTH AMERICA BOTULINUM TOXIN MARKET, COUNTRY OUTLOOK, 2022 & 2032 (IN %)

FIGURE 35: UNITED STATES BOTULINUM TOXIN MARKET, 2023-2032 (IN $ MILLION)

FIGURE 36: CANADA BOTULINUM TOXIN MARKET, 2023-2032 (IN $ MILLION)

FIGURE 37: EUROPE BOTULINUM TOXIN MARKET, COUNTRY OUTLOOK, 2022 & 2032 (IN %)

FIGURE 38: UNITED KINGDOM BOTULINUM TOXIN MARKET, 2023-2032 (IN $ MILLION)

FIGURE 39: GERMANY BOTULINUM TOXIN MARKET, 2023-2032 (IN $ MILLION)

FIGURE 40: FRANCE BOTULINUM TOXIN MARKET, 2023-2032 (IN $ MILLION)

FIGURE 41: ITALY BOTULINUM TOXIN MARKET, 2023-2032 (IN $ MILLION)

FIGURE 42: SPAIN BOTULINUM TOXIN MARKET, 2023-2032 (IN $ MILLION)

FIGURE 43: NORDIC COUNTRIES BOTULINUM TOXIN MARKET, 2023-2032 (IN $ MILLION)

FIGURE 44: POLAND BOTULINUM TOXIN MARKET, 2023-2032 (IN $ MILLION)

FIGURE 45: REST OF EUROPE BOTULINUM TOXIN MARKET, 2023-2032 (IN $ MILLION)

FIGURE 46: ASIA-PACIFIC BOTULINUM TOXIN MARKET, COUNTRY OUTLOOK, 2022 & 2032 (IN%)

FIGURE 47: CHINA BOTULINUM TOXIN MARKET, 2023-2032 (IN $ MILLION)

FIGURE 48: JAPAN BOTULINUM TOXIN MARKET, 2023-2032 (IN $ MILLION)

FIGURE 49: INDIA BOTULINUM TOXIN MARKET, 2023-2032 (IN $ MILLION)

FIGURE 50: SOUTH KOREA BOTULINUM TOXIN MARKET, 2023-2032 (IN $ MILLION)

FIGURE 51: SINGAPORE BOTULINUM TOXIN MARKET, 2023-2032 (IN $ MILLION)

FIGURE 52: THAILAND BOTULINUM TOXIN MARKET, 2023-2032 (IN $ MILLION)

FIGURE 53: AUSTRALIA & NEW ZEALAND BOTULINUM TOXIN MARKET, 2023-2032 (IN $ MILLION)

FIGURE 54: REST OF ASIA-PACIFIC BOTULINUM TOXIN MARKET, 2023-2032 (IN $ MILLION)

FIGURE 55: REST OF WORLD BOTULINUM TOXIN MARKET, REGIONAL OUTLOOK, 2022 & 2032 (IN %)

FIGURE 56: LATIN AMERICA BOTULINUM TOXIN MARKET, 2023-2032 (IN $ MILLION)

FIGURE 57: MIDDLE EAST & AFRICA BOTULINUM TOXIN MARKET, 2023-2032 (IN $ MILLION)

FAQ’s

FAQs

In addition to China, South Korea is expected to experience potential growth in the Asia-Pacific region for the global botulinum toxin market due to the availability of high-tech products, growing public awareness of cosmetic surgery, an aging population, and the prevalence of the population that is obsessed with beauty.

Type A botulinum toxin was initially used to treat ‘crossed eye’ but is now used to treat migraines, muscle spasms, and facial wrinkles for aesthetic purposes.

Request Customization
Request Customization
Request Free Sample